Recently, Claudia and colleagues found that ellagic acid showed antiproliferation effects in four bladder cancer cell lines, inhibiting extracellular matrix invasion and migration; moreover, the expression of PD-L1 in UM-UC-3 and T24 cells were downregulated after ellagic acid treatment. The gene discussed is CD274; the disease is urinary bladder carcinoma.